” Artificial Pancreas approved by FDA
” Sounds great doesn’t it? Its sadly right up there with “Scientists find way to cure diabetes”…in mice. Well, its not quite that bad but it is media hype that does not quite match the reality of the innovation.
The Medtronic Veo
insulin pump has been available in Canada for quite some time. For a change, we were able to avail of a new technology before the US market. In this case, it means availing of a technology that shuts down your insulin pump if your CGM tells the pump that you are low and dropping. This is a pretty great feature but does not for many equate to a true “artificial pancreas”.
A number of people in the diabetes community feel that a true artificial pancreas is more in keeping with Dr. Ed Damiano’s Bionic Pancreas
project rather than these smarter pumps. His pro-type has been used on adults and children with Type 1 diabetes in real world settings. A bulky model at that moment, but it has given people with Type 1 diabetes a freedom that they have not experienced since prior to their diagnosis.
Dr. Damiano’s approach combines the use of insulin, glucagon, a CGM, a smart insulin pump, and finally an iPhone. With all of this, he is able to create a pancreas for people like his son who live with Type 1. Those who have listened to his presentation (like myself) walk away amazed and inspired. Those who have used the system
talk of an experience like nothing that they have ever imagined before. They were able to enjoy meals without carb counting. They had nights without testing. They experienced relatively stable bg levels. It is truly amazing.
This research is not funded by an insulin pump company. This researched is fueled by a father’s desire to keep his son safe. David Damiano was diagnosed with Type 1 diabetes at the age of 11 months. This amazing project has given my own son hope where he didn’t have a lot before.
There are many great changes in the wind for people living with diabetes. Whether we are looking at a bionic pancreas, an artificial pancreas, or simply the improved accuracy of Continuous Glucose Monitoring systems. Diabetes care has moved forward a lot since our journey began over 13 years ago. I am excited to see it move forward much further in the next 13! The next challenge will be to ensure that people living with diabetes will have the ability to access these improved technologies.